1
|
Nuic D, van de Weijer S, Cherif S, Skrzatek A, Zeeboer E, Olivier C, Corvol JC, Foulon P, Pastor JZ, Mercier G, Lau B, Bloem BR, De Vries NM, Welter ML. Home-based exergaming to treat gait and balance disorders in patients with Parkinson's disease: A phase II randomized controlled trial. Eur J Neurol 2024; 31:e16055. [PMID: 37691341 DOI: 10.1111/ene.16055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2023] [Revised: 07/26/2023] [Accepted: 08/21/2023] [Indexed: 09/12/2023]
Abstract
BACKGROUND Exergaming has been proposed to improve gait and balance disorders in Parkinson's disease (PD) patients. We aimed to assess the efficacy of a home-based, tailored, exergaming training system designed for PD patients with dopa-resistant gait and/or balance disorders in a controlled randomized trial. METHODS We recruited PD patients with dopa-resistant gait and/or balance disorders. Patients were randomly assigned (1:1 ratio) to receive 18 training sessions at home by playing a tailored exergame with full-body movements using a motion capture system (Active group), or by playing the same game with the computer's keyboard (Control group). The primary endpoint was the between-group difference in the Stand-Walk-Sit Test (SWST) duration change after training. Secondary outcomes included parkinsonian clinical scales, gait recordings, and safety. RESULTS Fifty PD patients were enrolled and randomized. After training, no significant difference in SWST change was found between groups (mean change SWST duration [SD] -3.71 [18.06] s after Active versus -0.71 [3.41] s after Control training, p = 0.61). Some 32% of patients in the Active and 8% in the Control group were considered responders to the training program (e.g., SWST duration change ≥2 s, p = 0.03). The clinical severity of gait and balance disorders also significantly decreased after Active training, with a between-group difference in favor of the Active training (p = 0.0082). Home-based training induced no serious adverse events. CONCLUSIONS Home-based training using a tailored exergame can be performed safely by PD patients and could improve gait and balance disorders. Future research is needed to investigate the potential of exergaming.
Collapse
Affiliation(s)
- Dijana Nuic
- Paris Brain Institute, CNRS UMR 7225, INSERM 1127, Sorbonne University, Paris, France
- LabCom Brain e-Novation, Paris Brain Institute, Paris, France
| | - Sjors van de Weijer
- Donders Institute for Brain, Cognition, and Behavior and Department of Neurology, Center of Expertise for Parkinson and Movement, Radboud University Medical Center, Nijmegen, The Netherlands
- Department of Neurology, Maastricht University Medical Center, Maastricht, The Netherlands
| | - Saoussen Cherif
- Paris Brain Institute, CNRS UMR 7225, INSERM 1127, Sorbonne University, Paris, France
- LabCom Brain e-Novation, Paris Brain Institute, Paris, France
| | - Anna Skrzatek
- Paris Brain Institute, CNRS UMR 7225, INSERM 1127, Sorbonne University, Paris, France
| | - Eline Zeeboer
- Donders Institute for Brain, Cognition, and Behavior and Department of Neurology, Center of Expertise for Parkinson and Movement, Radboud University Medical Center, Nijmegen, The Netherlands
| | - Claire Olivier
- Paris Brain Institute, CNRS UMR 7225, INSERM 1127, Sorbonne University, Paris, France
- PANAM core facility, INSERM 1127, Paris Brain Institute, Paris, France
| | - Jean-Christophe Corvol
- Paris Brain Institute, CNRS UMR 7225, INSERM 1127, Sorbonne University, Paris, France
- Clinical Investigation Center, Assistance Publique Hôpitaux de Paris, Paris, France
| | - Pierre Foulon
- LabCom Brain e-Novation, Paris Brain Institute, Paris, France
- GENIOUS Healthcare, Montpellier, France
| | - Jénica Z Pastor
- Biostatistics Department, CHU de Montpellier, Montpellier, France
| | - Gregoire Mercier
- Biostatistics Department, CHU de Montpellier, Montpellier, France
- IDESP UA11, Université de Montpellier, INSERM, Montpellier, France
| | - Brian Lau
- Paris Brain Institute, CNRS UMR 7225, INSERM 1127, Sorbonne University, Paris, France
| | - Bastiaan R Bloem
- Donders Institute for Brain, Cognition, and Behavior and Department of Neurology, Center of Expertise for Parkinson and Movement, Radboud University Medical Center, Nijmegen, The Netherlands
| | - Nienke M De Vries
- Donders Institute for Brain, Cognition, and Behavior and Department of Neurology, Center of Expertise for Parkinson and Movement, Radboud University Medical Center, Nijmegen, The Netherlands
| | - Marie-Laure Welter
- Paris Brain Institute, CNRS UMR 7225, INSERM 1127, Sorbonne University, Paris, France
- LabCom Brain e-Novation, Paris Brain Institute, Paris, France
- PANAM core facility, INSERM 1127, Paris Brain Institute, Paris, France
- CHU Rouen, Neurophysiology Department, Rouen University, Rouen, France
| |
Collapse
|